Similarly, experiments exploiting a fluorescent tetramer encoding the BDCA-2 CRD, showed that BDCA-2 binds to tumor cells (including ovarian, colon, pancreatic carcinoma and breast adenocarcinoma) but not to non-tumor cells such as primary B and T cells (121). This evidence concerns the gene CLEC4C and neoplasm.